- Q4 2023 Lisata Therapeutics Inc Earnings Call TranscriptFeb 29, 2024$3.21 (+4.61%)Earnings
- Q3 2023 Lisata Therapeutics Inc Earnings Call TranscriptNov 02, 2023$2.15 (+5.88%)Earnings
- Q2 2023 Lisata Therapeutics Inc Earnings Call TranscriptAug 15, 2023$2.71Earnings
- Lisata Therapeutics Inc Fireside Chat Hosted by H.C. Wainwright & Co LLC (Virtual) TranscriptJun 21, 2023
- Q1 2023 Lisata Therapeutics Inc Earnings Call TranscriptMay 09, 2023$3.18Earnings
- Q4 2022 Lisata Therapeutics Inc Earnings Call TranscriptMar 30, 2023$3.33Earnings
- Lisata Therapeutics Inc at OTC Markets Life Science Investor Forum (Virtual) TranscriptMar 09, 2023
- Q3 2022 Lisata Therapeutics Inc Earnings Call TranscriptNov 10, 2022$4.06Earnings
- Q2 2022 Caladrius Biosciences Inc Earnings Call TranscriptAug 04, 2022$7.46 (+0.24%)Earnings
- Caladrius Biosciences Inc Provides Update on Phase 2b FREEDOM Trial Conference Call and Webcast TranscriptMay 24, 2022
- Q1 2022 Caladrius Biosciences Inc Earnings Call TranscriptMay 05, 2022$7.82Earnings
- Caladrius Biosciences Inc & Cend Therapeutics Definitive Merger Agreement Call TranscriptApr 27, 2022
- Q4 2021 Caladrius Biosciences Inc Earnings Call TranscriptMar 22, 2022$10.97 (-1.16%)Earnings
- Q3 2021 Caladrius Biosciences Inc Earnings Call TranscriptNov 04, 2021$17.55 (+0.80%)Earnings
- Q2 2021 Caladrius Biosciences Inc Earnings Call TranscriptAug 05, 2021$19.79 (+2.68%)Earnings
- Caladrius Biosciences Inc at LD Micro Virtual Zooming Conference TranscriptJul 29, 2021
- Q1 2021 Caladrius Biosciences Inc Earnings Call TranscriptMay 06, 2021$22.65 (-3.08%)Earnings
- Q4 2020 Caladrius Biosciences Inc Earnings Call TranscriptFeb 25, 2021$29.85 (-2.21%)Earnings
- Q3 2020 Caladrius Biosciences Inc Earnings Call TranscriptNov 05, 2020$35.1Earnings
- Q2 2020 Caladrius Biosciences Inc Earnings Call TranscriptAug 13, 2020$34.2Earnings
- Caladrius Biosciences Inc Annual Shareholders Meeting TranscriptJun 18, 2020
- Q1 2020 Caladrius Biosciences Inc Earnings Call TranscriptMay 07, 2020$28.2Earnings
- Q4 2019 Caladrius Biosciences Inc Earnings Call TranscriptMar 05, 2020$44.25Earnings
- Q3 2019 Caladrius Biosciences Inc Earnings Call TranscriptNov 06, 2019$44.25Earnings
- Q2 2019 Caladrius Biosciences Inc Earnings Call TranscriptAug 08, 2019$44.25Earnings
- Q1 2019 Caladrius Biosciences Inc Earnings Call TranscriptMay 09, 2019$54Earnings
Caladrius Biosciences Inc at LD Micro Virtual Zooming Conference Transcript
It is truly a privilege to introduce our next presenter. Based out of Basking Ridge, New Jersey, Caladrius Biosciences, ticker CLBS on the NASDAQ, is dedicated to the development of cellular therapies designed to reverse disease. The company's current product candidates include CLBS16, which is for the treatment of coronary microvascular dysfunction, or CMD; CLBS12 which targets Buerger's Disease in the U.S.; as well as CLBS201 designed to assess the safety and efficacy of CD34+ cell therapy as a treatment for diabetic kidney disease.
Caladrius has participated in our conferences over the years, and I have the utmost pleasure of spending a day with management, mostly Second Bay Area traffic and discussing my fast food eating habits. The only thing I really concluded from the trip is that jack-in-the-box is probably not good for your overall health. And the management team here takes incredible pride in what they do each and every day.
Joining us on the call today, it is my privilege and pleasure to welcome the President and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)